Viruses: exam questions

7 questions, 23 marks. Write your answers on paper, then open each mark scheme.

Spec A2.3
HL only (what this means)HL only: additional Higher Level content, only for HL students. SL students can skip it. What the labels mean
Questions and mark scheme (PDF)5 pages

Question 1

Paper 1A style

HL only (what this means)HL only: additional Higher Level content, only for HL students. SL students can skip it. What the labels mean

Which feature is shared by all viruses?

  1. An envelope derived from host cell membrane
  2. A capsid made of protein
  3. Double-stranded DNA
  4. The enzyme reverse transcriptase
[1 mark]
Show mark scheme for question 1

Answer: B [1]

Question 2

Paper 1A style

HL only (what this means)HL only: additional Higher Level content, only for HL students. SL students can skip it. What the labels mean

During the lysogenic cycle of bacteriophage lambda, what happens to the viral DNA?

  1. It is packed into new capsids straight away.
  2. It is transcribed to make enzymes that lyse the cell.
  3. It is integrated into the host chromosome and replicated when the host divides.
  4. It is broken down by host enzymes.
[1 mark]
Show mark scheme for question 2

Answer: C [1]

Question 3

Paper 1B style

HL only (what this means)HL only: additional Higher Level content, only for HL students. SL students can skip it. What the labels mean

The viral load (number of copies of HIV RNA per cm³ of blood) was monitored in two groups of patients. One group took a single antiviral drug and the other took a combination of three drugs with different targets. The data are for practice. (a) Calculate the percentage decrease in viral load in the single-drug group between week 0 and week 8. [1] (b) Describe the trend in viral load in the single-drug group after week 8. [1] (c) Explain the change in viral load in the single-drug group after week 8. [2] (d) Suggest why the viral load stayed low in the combination group. [2]

Viral load in patients with HIV (practice data)
Time / weeksSingle drug / copies per cm³Three-drug combination / copies per cm³
0100 000100 000
42 0001 500
81 500200
129 000below 50
1640 000below 50
2490 000below 50
[6 marks]
Show mark scheme for question 3
  • (a) (100 000 − 1 500) ÷ 100 000 × 100 = 98.5% [1]
  • (b) increases from 1 500 to 90 000 copies per cm³ / rises back almost to the starting level by week 24 [1]
  • (c) HIV has a high mutation rate / reverse transcriptase makes errors / does not proofread [1]
  • (c) some variants are resistant to the drug [1]
  • (c) the drug selects for resistant variants, which multiply / natural selection [1]
  • max 2 for (c)
  • (d) a variant would need mutations giving resistance to all three drugs at the same time [1]
  • (d) this is very unlikely / the probability is very low [1]
  • (d) the drugs act on different targets, so replication is blocked at more than one stage [1]
  • max 2 for (d)

Question 4

Paper 2A style

HL only (what this means)HL only: additional Higher Level content, only for HL students. SL students can skip it. What the labels mean

Compare and contrast the structure of bacteriophage lambda and HIV. [4]

[4 marks]
Show mark scheme for question 4
  • both have a protein capsid [1]
  • both have nucleic acid as genetic material / both lack cytoplasm [1]
  • lambda has double-stranded DNA; HIV has single-stranded RNA [1]
  • lambda is not enveloped; HIV is enveloped in host cell membrane [1]
  • HIV has glycoproteins in its envelope that bind host receptors; lambda binds the host with its tail [1]
  • lambda has an icosahedral head and a tail; HIV has a cone-shaped capsid [1]
  • HIV carries reverse transcriptase / integrase / protease; lambda carries no enzymes [1]
  • max 4, with at least one similarity for full marks

Question 5

Paper 2B style

HL only (what this means)HL only: additional Higher Level content, only for HL students. SL students can skip it. What the labels mean

Describe the lytic cycle of bacteriophage lambda. [5]

[5 marks]
Show mark scheme for question 5
  • the phage tail attaches to specific receptors on E. coli [1]
  • viral DNA is injected; the capsid stays outside [1]
  • the viral DNA circularises [1]
  • viral genes are transcribed by host RNA polymerase [1]
  • and translated by host ribosomes to make capsid proteins / viral enzymes [1]
  • the host supplies ATP / energy, nucleotides and amino acids [1]
  • viral DNA is replicated many times [1]
  • new phages are assembled / DNA is packed into heads [1]
  • viral enzymes break down the cell wall [1]
  • the cell lyses / bursts, releasing many (about 100) phages [1]
  • released phages infect other cells [1]
  • max 5

Question 6

Paper 2A style

HL only (what this means)HL only: additional Higher Level content, only for HL students. SL students can skip it. What the labels mean

Outline the evidence that viruses have several origins. [3]

[3 marks]
Show mark scheme for question 6
  • viruses are very diverse in structure / in genetic material (DNA or RNA, single- or double-stranded) [1]
  • suggesting they did not all descend from one common ancestor [1]
  • their shared features may be the result of convergent evolution [1]
  • because all share the same extreme obligate parasitism / way of life [1]
  • the genetic code is shared with living organisms, suggesting origins from cells [1]
  • some may have escaped from cells (e.g. as plasmids), others reduced from parasitic cells [1]
  • max 3

Question 7

Paper 2A style

HL only (what this means)HL only: additional Higher Level content, only for HL students. SL students can skip it. What the labels mean

Explain why a new influenza vaccine is produced each year. [3]

[3 marks]
Show mark scheme for question 7
  • influenza has an RNA genome with a high mutation rate / its RNA polymerase does not proofread [1]
  • mutations change the surface antigens haemagglutinin / neuraminidase [1]
  • this is antigenic drift [1]
  • antibodies / memory cells from earlier vaccines no longer bind / recognise the new strain [1]
  • segments from two strains can mix in one host (antigenic shift), producing a new subtype [1]
  • the vaccine is matched to the strains predicted to circulate [1]
  • max 3